Pluri Inc

NASDAQ:PLUR   12:48:43 AM EDT
5.15
+0.13 (+2.59%)
6:00:53 PM EDT: $4.71 -0.44 (-8.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)40.30M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.4 Million
Adjusted EPS-$0.73
See more estimates
10-Day MA$5.21
50-Day MA$4.86
200-Day MA$4.73
See more pivots

Pluri Inc Stock, NASDAQ:PLUR

MATAM Advanced Technology Park, Building No. 5, Haifa, Haifa 3508409
Israel
Phone: +972.74.710.8600
Number of Employees: 118

Description

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.